Relmada Therapeutics, Inc. Share Price
RLMDRelmada Therapeutics, Inc. Stock Performance
Open $3.71 | Prev. Close $3.90 | Circuit Range N/A |
Day Range $3.62 - $3.94 | Year Range $0.24 - $5.10 | Volume 27,575 |
Average Traded $3.87 |
Relmada Therapeutics, Inc. Share Price Chart
About Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Relmada Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $3.71 | $3.90 | +8.03% |
05-Feb-26 | $3.67 | $3.61 | -1.90% |
04-Feb-26 | $3.78 | $3.68 | -3.16% |
03-Feb-26 | $3.84 | $3.80 | -0.65% |
02-Feb-26 | $3.68 | $3.83 | +7.75% |
30-Jan-26 | $3.80 | $3.55 | -9.44% |
29-Jan-26 | $3.92 | $3.92 | -0.76% |
FAQs on Relmada Therapeutics, Inc. Share Price
Can I buy Relmada Therapeutics, Inc. shares in India?
What is the share price of Relmada Therapeutics, Inc.?
What is the 5 year returns of Relmada Therapeutics, Inc.?
What are the high & low stock price of Relmada Therapeutics, Inc. today?
What is the 52-week high and low of Relmada Therapeutics, Inc. stock?